Literature DB >> 28984663

Practical management of concomitant acute heart failure and worsening renal function in the emergency department.

João Pedro Ferreira1,2,3, Tahar Chouihed1,4,2, Pierre Nazeyrollas5, Bruno Levy1,6, Marie F Seronde7,8,9, Pascal Bilbault10,11, François Braun12, Gérald Roul13,14, David Kénizou15, Noura Zannad16,2, Nicolas Girerd1,2, Patrick Rossignol1,2.   

Abstract

Worsening renal function (i.e. any increase in creatinine or decrease in the estimated glomerular filtration rate) is common in patients admitted for acute heart failure in the emergency department. Although worsening renal function (WRF) has been associated with the occurrence of dismal outcomes, this only appears to be the case when associated with clinical deterioration. However, if the clinical status of the patient is improving, a certain increase in serum creatinine may be acceptable. This WRF, which is not associated with clinical deterioration or adverse outcomes (e.g. during treatment up-titration), has been referred to as 'pseudo-WRF' and should not detract clinicians from targeting 'guideline-recommended' therapies. This is an important message for emergency physicians to pursue diuretics as long as signs of pulmonary congestion persist to improve the clinical status of the patient. In the present review, we aim to provide clinicians in acute settings with an integrative and comprehensive approach to cardiorenal interactions in acute heart failure.

Entities:  

Mesh:

Year:  2018        PMID: 28984663     DOI: 10.1097/MEJ.0000000000000505

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  2 in total

Review 1.  Decompensated Heart Failure and Renal Failure: What Is the Current Evidence?

Authors:  Agata Bielecka-Dabrowa; Breno Godoy; Joerg C Schefold; Michael Koziolek; Maciej Banach; Stephan von Haehling
Journal:  Curr Heart Fail Rep       Date:  2018-08

2.  Ultrasound dynamic monitoring of IVCD to guide application of CRRT in patients with renal failure combined with acute heart failure.

Authors:  Guang Yu; Shaoyu Tao; Yingzhi Jin; Wanxia Li; Zanqun Hu; Xiaowei Fang
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.